Literature DB >> 27043262

Aiming High--Changing the Trajectory for Cancer.

Douglas R Lowy1, Francis S Collins1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27043262      PMCID: PMC5101951          DOI: 10.1056/NEJMp1600894

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.

Authors:  Jennifer A H Bell; Lynda G Balneaves
Journal:  Support Care Cancer       Date:  2015-01-17       Impact factor: 3.603

2.  Oncology patient-centered medical home.

Authors:  John D Sprandio
Journal:  J Oncol Pract       Date:  2012-05       Impact factor: 3.840

  2 in total
  28 in total

1.  Leveraging premalignant biology for immune-based cancer prevention.

Authors:  Avrum Spira; Mary L Disis; John T Schiller; Eduardo Vilar; Timothy R Rebbeck; Rafael Bejar; Trey Ideker; Janine Arts; Matthew B Yurgelun; Jill P Mesirov; Anjana Rao; Judy Garber; Elizabeth M Jaffee; Scott M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-16       Impact factor: 11.205

2.  Formalin-fixed paraffin-embedded sample conditions for deep next generation sequencing.

Authors:  Masayuki Nagahashi; Yoshifumi Shimada; Hiroshi Ichikawa; Satoru Nakagawa; Nobuaki Sato; Koji Kaneko; Keiichi Homma; Takashi Kawasaki; Keisuke Kodama; Stephen Lyle; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Surg Res       Date:  2017-07-27       Impact factor: 2.192

3.  Enigmas, priorities and opportunities in cancer epidemiology.

Authors:  Hans-Olov Adami; Olof Nyrén
Journal:  Eur J Epidemiol       Date:  2017-01-06       Impact factor: 8.082

4.  The Undergraduate Training in Genomics (UTRIG) Initiative: early & active training for physicians in the genomic medicine era.

Authors:  Rebecca L Wilcox; Patricia V Adem; Ebrahim Afshinnekoo; James B Atkinson; Leah W Burke; Hoiwan Cheung; Shoumita Dasgupta; Julia DeLaGarza; Loren Joseph; Robin LeGallo; Madelyn Lew; Christina M Lockwood; Alice Meiss; Jennifer Norman; Priscilla Markwood; Hasan Rizvi; Kate P Shane-Carson; Mark E Sobel; Eric Suarez; Laura J Tafe; Jason Wang; Richard L Haspel
Journal:  Per Med       Date:  2018-05-30       Impact factor: 2.512

5.  Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.

Authors:  Admassu N Lamu; Jan Abel Olsen
Journal:  Qual Life Res       Date:  2018-09-01       Impact factor: 4.147

6.  Cancer prevention from the perspective of global cancer burden patterns.

Authors:  Hiroki Nagai; Young Hak Kim
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 7.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

8.  Clonality in context: hematopoietic clones in their marrow environment.

Authors:  James N Cooper; Neal S Young
Journal:  Blood       Date:  2017-10-18       Impact factor: 22.113

9.  Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay.

Authors:  Pavalan Selvam; Meng-Chang Hsiao; Gregory Omerza; Daniel Bergeron; Shannon Rowe; Jasmina Uvalic; Melissa Soucy; Michael Peracchio; Shelbi Burns; Bridgette Meyers; Matthew Prego; Qian Nie; Guruprasad Ananda; Harshpreet Chandok; Kevin Kelly; Andrew Hesse; Honey V Reddi
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

Review 10.  Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell.

Authors:  Nazish Sayed; Mohamed Ameen; Joseph C Wu
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.